Next, the tumor inflammatory signature that consisted of 18 genes associated with PD-1/PD-L1 inhibition, antigen presentation, chemokine secretion, and adaptive immune responses was assessed for each HCC subtype (Table 4). The gene discussed is CD274; the disease is hepatocellular carcinoma.